Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,451Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 63PF PRISM CV

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-1283

Delist Requested :

Patent Use Description : A METHOD OF TREATING C...

Patent Expiration Date : 2025-12-11

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-1283

Delist Requested :

Patent Use Description : A METHOD OF TREATING C...

Patent Expiration Date : 2025-12-11

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-1283

Delist Requested :

Patent Use Description : A METHOD OF TREATING C...

Patent Expiration Date : 2025-12-11

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-3708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-11

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-3707

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-11

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-3707

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-11

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-3708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-11

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-3708

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-11

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 7417148

Drug Substance Claim :

Drug Product Claim :

Application Number : 203341

Patent Use Code : U-3707

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-11

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BOSUTINIB MONOHYDRATE

US Patent Number : 11103497

Drug Substance Claim :

Drug Product Claim :

Application Number : 217729

Patent Use Code : U-3216

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-28

blank